<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230530058343N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-07-09</date_registration>
      <primary_sponsor>The University of Faisalabad</primary_sponsor>
      <public_title>Comparing Mulligan and Maitland Mobilization Techniques for Chronic Non-SpecificLow Back Pain Patients</public_title>
      <acronym>RCT</acronym>
      <scientific_title>Comparative effects of Mulligan and Maitland Mobilization Techniques in chronic Non- Specific Low Back Pain patients.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-12-24</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/70957</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Diagnostic, Randomization description: A Single Blinded Randomized Clinical Trial was conducted for treatment and the unit of randomization through individual. Purposive sampling Technique was used to collect sample and two groups will randomly allocated by lottery method. Total 44 patients was assessed for eligibility criteria, 2 excluded for not meeting the inclusion criteria and 1 refused to participate. then Randamization is done and allocated into two groups Mulligan group and Maitland Group. The Mulligan group has total 21 participant from 21 participant 1 is exclude for not following the treatment session . and the Maitland group has 20 participants. Both groups results has been analyzed through spss version, Blinding description: The participants in both Mulligan group and Maitland group are blinded from treatment after giving informed consent.</study_design>
      <phase>1-2</phase>
      <hc_freetext>Chronic Non-Specific Low Back Pain.</hc_freetext>
      <i_freetext>Intervention group: Mulligan Group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Comparative effects of Mulligan and Maitland Mobilization Techniques in chronic Non- Specific Low Back Pain patients.

When:
not sure

To whom:
The University of Faisalabad

Conditions:
For Research Purpose

Where to obtain:
website and Email

How to obtain:
not sure

Comments:
Please comment them when you study the article.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>hafiza Mubashra Zahid, Maryam Safdar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>near manawala road</address>
        <city>faisalabad</city>
        <country1>Pakistan</country1>
        <zip>817185</zip>
        <telephone>+92 41 8750971</telephone>
        <email>studentaffairsew@tuf.edu.pk</email>
        <affiliation>The University of Faisalabad</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hafiza Mubashra Zahid</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>near manawala road</address>
        <city>Faisalabad</city>
        <country1>Pakistan</country1>
        <zip>38000</zip>
        <telephone>+92 41 87509715</telephone>
        <email>studentaffairsew@tuf.edu.pk</email>
        <affiliation>The University of Faisalabad</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Both gender (Male /Female) with the age 20-40.
Patient having low back pain with duration of at least 4 months.
At least moderate pain according to NPRS
Minimum flexion of lumbar was 37±12°
Minimum extension of lumbar was 14±4°
Minimum kinesiophobia was 40±4.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Vascular disease
Diagnosed with systematic disease i.e. TB of spine
Diagnosed with specific disease of LBP (arthritis, SIJ pain, and osteoporosis)
Recent fracture or history of fracture
Osteoporosis
Pregnancy or C-section 6 months ago
Previous hip or back surgery or fracture less than half year prior
Abdominal surgery inside the past 90 days
Treatment of existing back pain by another health care professional within one week
Red flags i.e. tumor, infection, open wound (clinical signs of conceivable serious spinal or foundational messes)
Diagnosed with neurological disease or radiculopathy
Patient who do not receive any PT/ exercise plan from previous 3 months
Refusal for consent.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Low back pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Mulligan Group</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>1-Pain 2-Range of Motion. Timepoint: 1-Pain intensity = Numeric Pain Rating Scale (NPRS). 2-Lumbar Range of Motion = Measuring tape	3-. Method of measurement: 1-Pain intensity = Numeric Pain Rating Scale (NPRS). On a Numeric Pain Rating Scale (NPRS), patients were approached to check the number somewhere in the range of 0 and 10, 0 and 20 or 0 and 100 that best matches their aggravation power. Zero as a rule addresses 'no aggravation' and as far as possible addresses 'most exceedingly terrible conceivable torment'  2-Lumbar Range of Motion = Measuring tape One of the most common tape measurement procedures used to measure lumbar flexion involves a technique pioneered by Schubert, who described the original two- point method for measuring spinal flexion and later modified it to measure spinal flexion. This makes one mark at the lumbosacral. Junction and the second mark are made 10 cm above the first mark, with the subject in a neutral position with the spine. After the stationary subject bends forward as far as possible, the amount of flexion in the spine is estimated by increasing the distance between the first and second points. Because the tape measure method relies on the stretching or distraction of the skin over the spine, this technique (and modifications of the technique) is sometimes called the skin distraction method. Bone landmarks for tape measure indicate ROM of lumbar extension, midline of spine consistent with PSIS, cm above baseline marker.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Kinesiophobia. Timepoint: kinesiophobia= Tampa Scale. Method of measurement: The Tampa Scale for Kinesiophobia has a complete score scope of 17-68, with 17 showing no kinesiophobia, 68 demonstrating extreme kinesiophobia, and a score of ±37 showing the presence of kinesiophobia. The contracted variant keeps up with things 1, 2, 3, 5, 6, 7, 10, 11, 13, 15 and 17 from the first TSK- 11 scale and has a score scope of 11-44.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id>https://pjmhsonline.com/index.php/pjmhs/article/view/2222</sec_id>
        <issuing_authority>RCT</issuing_authority>
      </secondary_id>
      <secondary_id>
        <sec_id>https://www.thehealerjournal.com/index.php/templates/article/view/83</sec_id>
        <issuing_authority>RCT</issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>investigator initiated trail</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-12-24</approval_date>
        <contact_name>Ethics Comittee of The University of Faisalabad</contact_name>
        <contact_address>Near to manawala road, Faisalabad Faisalabad Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
